Nanotrope Receives Phase II Grant from NASA to Advance Nanoscale Drug Delivery 03/02
NASA awarded Nanotrope Inc. The award-winning company's proposal took into account both NASA's outer space initiatives and commercial applications outside of NASA.
According to Dr. Donald Ackley, President and CEO of Nanotrope Inc., "With this funding from NASA, our research will allow us to rapidly advance the application of nanoscale drip technology for targeted drug delivery."
Topics related to Nanoscale Drug Delivery:
- Viruses for drug administration
- Companies that develop drug administration
- Nanotechnology news: Drug management
- Increased effectiveness of medications